{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:29:11Z","timestamp":1774085351999,"version":"3.50.1"},"reference-count":21,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1990,4]]},"abstract":"<jats:p content-type=\"fine-print\">\u2713 Seventeen patients with recurrent gliomas were treated with the combination of cyclophosphamide and vincristine. All but one had previously received and failed chemotherapy. Cyclophosphamide was administered at doses ranging from 250 to 1000 mg\/sq m by intravenous infusion on Days 1 and 2, and vincristine was given at a dose of 1.0 mg\/sq m (2 mg maximal dose) intravenously on Day 1; cycles were repeated every 4 weeks. Clinical and radiographic improvement was observed in eight of 16 evaluable patients, and four other patients had stabilization of previously progressive disease. Four patients are alive and off treatment without evidence of recurrence for a median period of 37 months; these included an adult with a cerebral anaplastic astrocytoma now more than 51 months after therapy. Toxicity included moderately severe myelosuppression that required hospitalization in seven patients. These results indicate that the combination of cyclophosphamide and vincristine has activity in the treatment of recurrent gliomas, and warrant the use of these drugs in larger controlled studies, particularly if they can be used in conjunction with hematopoietic growth factors.<\/jats:p>","DOI":"10.3171\/jns.1990.72.4.0583","type":"journal-article","created":{"date-parts":[[2009,5,13]],"date-time":"2009-05-13T18:19:39Z","timestamp":1242238779000},"page":"583-588","source":"Crossref","is-referenced-by-count":63,"title":["Treatment of patients with recurrent gliomas with cyclophosphamide and vincristine"],"prefix":"10.3171","volume":"72","author":[{"given":"Darryl C.","family":"Longee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry S.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Albright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Jerry","family":"Oakes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph O.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Clifford","family":"Schold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1","series-title":"Invest Radiol","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/00004424-198812000-00001","article-title":"Microcomputer-based technique for 3-D reconstruction and volume measurement of computed tomographic images. Part 1: Phantom studies.","volume":"23","author":"Albright","year":"1988"},{"key":"b2","series-title":"Invest Radiol","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1097\/00004424-198812000-00002","article-title":"Microcomputer-based technique for 3-D reconstruction and volume measurement of computed tomographic images. Part 2: Anaplastic primary brain tumors.","volume":"23","author":"Albright","year":"1988"},{"key":"b3","series-title":"Semin Oncol","first-page":"110","article-title":"Brain tumors in children: current cooperative and institutional chemotherapy trials in newly diagnosed and recurrent disease.","volume":"13","author":"Allen","year":"1986"},{"key":"b4","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3171\/jns.1981.55.5.0749","article-title":"High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children.","volume":"55","author":"Allen","year":"1981"},{"key":"b5","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1056\/NEJM198809083191001","article-title":"Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.","volume":"319","author":"Antman","year":"1988"},{"key":"b6","series-title":"Blood","first-page":"130","article-title":"Effects of recombinant human G-CSF and GM-CSF on cytopenias associated with repeated cycles of chemotherapy in primates.","volume":"70","author":"Bonilla","year":"1987"},{"key":"b7","series-title":"J Neuropathol Exp Neurol","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/00005072-198107000-00005","article-title":"Growth and chemotherapeutic response in athymic mice of tumors arising from human glioma-derived cell lines.","volume":"40","author":"Bullard","year":"1981"},{"key":"b8","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1056\/NEJM198804073181401","article-title":"Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstruction after high-dose chemotherapy and autologous bone marrow transplantation.","volume":"318","author":"Brandt","year":"1988"},{"key":"b9","series-title":"Proc Natl Acad Sci USA","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1073\/pnas.82.9.2985","article-title":"O6-alkylguanine-DNA alkyltransferase activity correlates with therapeutic response of human rhabdomyosarcoma xenografts to MeCCNU.","volume":"82","author":"Brent","year":"1985"},{"key":"b10","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1200\/JCO.1983.1.1.38","article-title":"Evaluation of prognostic factors in chemotherapy of recurrent brain tumors.","volume":"1","author":"Eagan","year":"1983"},{"key":"b11","series-title":"Cancer Treat Rep","first-page":"1179","article-title":"Brain tumor chemotherapy: an evaluation of agents in current use for Phase II and III trials.","volume":"64","author":"Edwards","year":"1980"},{"key":"b12","series-title":"Am J Med","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/0002-9343(80)90472-6","article-title":"Dose: a critical factor in cancer chemotherapy.","volume":"69","author":"Frei","year":"1980"},{"key":"b13","series-title":"Cancer Res","first-page":"4189","article-title":"Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents.","volume":"48","author":"Friedman","year":"1988"},{"key":"b14","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1227\/00006123-198603000-00014","article-title":"Efficacy of vincristine and cyclophosphamide in the therapy of recurrent medulloblastoma.","volume":"18","author":"Friedman","year":"1986"},{"key":"b15","series-title":"Blood","first-page":"135","article-title":"A Phase I\/II study of rhG-CSF in cancer patients at risk for chemotherapy-induced neutropenia.","volume":"70","author":"Gabrilove","year":"1987"},{"key":"b16","series-title":"Semin Oncol","first-page":"27","article-title":"Clinical applications of colony-stimulating factors.","volume":"15","author":"Groopman","year":"1988"},{"key":"b17","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/jns.1988.68.1.0001","article-title":"Chemotherapy for malignant gliomas.","volume":"68","author":"Kornblith","year":"1988"},{"key":"b18","series-title":"J Clin Invest","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1172\/JCI113106","article-title":"Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model.","volume":"80","author":"Nienhuis","year":"1987"},{"key":"b19","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3171\/jns.1976.45.2.0135","article-title":"Response to vincristine of recurrent brain tumors in children.","volume":"45","author":"Rosenstock","year":"1976"},{"key":"b20","series-title":"Cancer Treat Rep","first-page":"811","article-title":"Treatment of five subcutaneous human glioma tumor lines in athymic mice with carmustine, procarbazine, and mithramycin.","volume":"67","author":"Schold","year":"1983"},{"key":"b21","series-title":"Cancer Treat Rep","first-page":"849","article-title":"Therapeutic profile of the human glioma line D-54 MG in athymic mice.","volume":"71","author":"Schold","year":"1987"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/72\/4\/article-p583.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/72\/4\/article-p583.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/72\/4\/article-p583.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T22:02:21Z","timestamp":1679868141000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/72\/4\/article-p583.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,4]]},"references-count":21,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3171\/jns.1990.72.4.0583","relation":{},"ISSN":["0022-3085"],"issn-type":[{"value":"0022-3085","type":"print"}],"subject":[],"published":{"date-parts":[[1990,4]]}}}